Riggs Technology Holdings, LLC v. Vagaro, Inc.

Opinion

Case: 22-1469 Document: 39 Page: 1 Filed: 01/17/2023

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

RIGGS TECHNOLOGY HOLDINGS, LLC, Plaintiff-Appellant

v.

VAGARO, INC., Defendant-Appellee ______________________

2022-1469 ______________________

Appeal from the United States District Court for the Northern District of California in No. 3:21-cv-07927-TSH, Magistrate Judge Thomas S. Hixson. ______________________

Decided: January 17, 2023 ______________________

WILLIAM PETERSON RAMEY, III, Ramey LLP, Houston, TX, for plaintiff-appellant.

SAL LIM, Kramer Day Alberti Lim Tonkovich & Belloli LLP, Burlingame, CA, for defendant-appellee. Also repre- sented by MARC BELLOLI, HONG LIN. ______________________

Before TARANTO, CHEN, and STOLL, Circuit Judges. Case: 22-1469 Document: 39 Page: 2 Filed: 01/17/2023

CHEN, Circuit Judge. Riggs Technology Holdings, LLC appeals from a deci- sion by the United States District Court for the Northern District of California holding that all claims of U.S. Patent No. 7,299,067 (’067 patent) are directed to patent-ineligible subject matter under 35 U.S.C. § 101. See Riggs Tech. Holdings, LLC v. Vagaro, Inc., No. 21-cv-07927-TSH, 2022 WL 74179, at *3 (N.D. Cal. Jan. 7, 2022). Our decision to- day in a separate case, Riggs Technology Holdings, LLC v. Cengage Learning, Inc., No. 22-1468, affirmed a decision by the United States District Court for the District of Massa- chusetts that also held that all claims of the ’067 patent are directed to patent-ineligible subject matter under 35 U.S.C. § 101. Our decision in case No. 22-1468 has thus resolved the patent eligibility of the claims on appeal. See BTG Int’l Ltd. v. Amneal Pharms. LLC, 923 F.3d 1063, 1076–77 (Fed. Cir. 2019). We therefore dismiss this appeal as moot. DISMISSED